Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer

Radiotherapy and Oncology

Volumn 44, Issue 1, 1997, Pages 9-15

  Wigren, Tuija ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Lung cancer; Prognostic factors; Prognostic index; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 0030739929     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00087-X     Document Type: Article

References (22)

1. Albain, K.S., Crowley, J.J., LeBlanc, M. and Livingston, R.B. Survival determinants in extensive-stage non-small cell lung cancer: The Southwest Oncology Group experience. J. Clin. Oncol. 9: 1618-1626, 1991.
2. Cox, J.D., Azarnia, N., Bychardt, R.W., Shin, K.H., Emami, B. and Pajak, T.F. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with ≥69.9 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8: 1543-1555, 1990.
3. Dixon, W.J., Brown, M.B., Engelman, L. and Jennrich, R.I. BMDP Statistical Software Manual. University of California Press, Berkeley, CA, 1990.
4. Feinstein, A.R. A new staging system for cancer and reappraisal of 'early' treatment and 'cure' by radical surgery. N. Engl. J. Med. 279: 747-753, 1968.
5. Feinstein, A.R. A clinical-severity staging system for patients with lung cancer. Medicine 68: 1-33, 1990.
6. Feld, R., Borges, M., Giner, V. et al. Prognostic factors for non-small cell lung cancer. Lung Cancer 11: 19-23, 1994.
7. Finnish Cancer Registry, The Institute for Statistical and Epidemiological Cancer Research. Cancer Incidence in Finland 1993. Cancer Statistics of the National Research and Development Centre for Welfare and Health. Cancer Society of Finland Publication No. 56, Helsinki, 1995.
8. Graham, M.V., Pajak, T.E., Herskovic, A.M., Emarni, B. and Perez, C.A. Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long term results. Int. J. Radiat. Oncol. Biol. Phys. 31: 819-825, 1995.
9. Hespanhol, V., Queiroga, H., Magalhães, A., Santos, A.R., Coelho, M. and Marques, A. Survival predictors in advanced non-small cell lung cancer. Lung Cancer 13: 253-267, 1995.
10. Jeremic, B., Shibamoto, Y., Acimovic, L. and Djuric, L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III lung cancer. J. Clin. Oncol. 13: 452-458, 1995.
11. Le Chevalier, T., Arriagada, R., Quoix, E. et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J. Natl. Cancer Inst. 83: 417-423, 1991.
12. Mountain, C.F. A new international staging system for lung cancer. Chest 89 (Suppl.): 225-233, 1986.
13. Paesmans, M., Sculier, J.P., Libert, P. et al. Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J. Clin. Oncol. 13: 1221-1230, 1995.
14. Perez, C.A., Pajak, T.F., Rubin, P. et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59: 1874-1881, 1987.
15. Sagman, U., Maki, E., Evans, W.K. et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J. Clin. Oncol. 9: 1639-1649, 1991.
16. Saunders, M.I. and Dische, S. Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int. J. Radiat. Oncol. Biol. Phys. 19: 1211-1215, 1991.
17. Sause, W.T., Scott, C., Taylor, S. et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J. Natl. Cancer Inst. 87: 198-205, 1995.
18. Schaake-Koning, C., van den Bogaert, W., Dalesio, O. et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N. Engl. J. Med. 326: 524-530, 1992.
19. Stanley, K. Prognostic factors for survival in patients with inoperable lung cancer. J. Natl. Cancer Inst. 65: 25-32, 1980.
20. Takigawa, N., Segawa, Y., Okahara, M. et al. Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 15: 67-77, 1996.
21. Wigren, T., Kellokumpu-Lehtinen, P. and Ojala, A. Radical radiotherapy of inoperable non-small cell lung cancer. Irradiation techniques and tumor characteristics in relation to local control and survival. Acta Oncol. 31: 555-561, 1992.
22. Wigren, T., Oksanen, H. and Kellokumpu-Lehtinen, P. A practical prognostic index of inoperable non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 123: 259-266, 1977.